RxDoctor Payments DataLook up a doctor →

Kamal Shemisa, MD

Cardiovascular Disease · Cincinnati, OHNPI 1326281007

Payments from drug & device makers

$418,439in general payments, 2019–2025

Across 980 payments — averaging $426.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$93K
  • Boehringer Ingelheim$60K
  • Amgen$44K
  • Pfizer$36K
  • Lilly USA, LLC$32K
  • Lexicon Pharmaceuticals, Inc.$32K
  • plus $121K from 36 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bayer81$92,951
Boehringer Ingelheim101$60,272
Amgen49$43,993
Pfizer67$35,702
Lilly USA, LLC38$32,173
Lexicon Pharmaceuticals, Inc.31$31,983
Merck66$28,267
Esperion Therapeutics, Inc.33$26,689
AstraZeneca66$24,413
Johnson & Johnson102$24,314
Novartis118$7,457
Amarin Pharma, Inc.72$5,315
Novo Nordisk49$1,421
Regeneron Healthcare Solutions, Inc.10$501
Boston Scientific15$384
AOP Health US, LLC1$354
Heartflow, Inc.3$348
Abbott6$317
E.r. Squibb & Sons, L.L.C.11$262
Alnylam Pharmaceuticals Inc.12$259
Astellas Pharma US Inc6$229
Daiichi Sankyo Inc.6$122
Bridgebio Pharma, Inc.4$80
Edwards Lifesciences3$75
Kestra Medical Technology Services, Inc.3$70
Irhythm Technologies, Inc.2$65
Scpharmaceuticals Inc.3$58
Lundbeck LLC4$56
Atricure, Inc.2$45
Beckman Coulter, Inc.2$36
Regeneron1$35
Kiniksa Pharmaceuticals International, PLC2$33
Inari Medical, Inc.1$25
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)2$22
Ionis Pharmaceuticals, Inc.1$18
Convatec Inc.1$16
Baxter Healthcare1$14
Terumo Medical Corporation1$14
Philips North America LLC1$14
Portola Pharmaceuticals, LLC1$13
Sanofi-aventis U.S. LLC1$13
Actelion Pharmaceuticals US, Inc.1$10

How this compares

$418,439 in reported general payments places this provider in the 95th percentile of 827 cardiovascular disease providers in Ohio.

See all cardiovascular disease providers in Ohio →

Medicare billing

Part B allowed, 2024
$174,294
Medicare patients
1,278
Services billed
2,731

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Cincinnati

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →